Literature DB >> 36257981

Fludarabine- and low-dose cyclophosphamide-based conditioning regimens provided favorable survival and engraftment for unmanipulated hematopoietic cell transplantation from unrelated donors and matched siblings in patients with Fanconi anemia: results from the CBMTR.

Lanping Xu1, Yue Lu2, Jing Chen3, Shuwen Sun4, Shaoyan Hu5, Shunqing Wang6, Xuedong Wu7, Yuan Sun8, Dingming Wan9, Yajing Xu10, Hui Jiang11, Chunfu Li12, Mei Lan13, Erlie Jiang14, Fei Li15, Sixi Liu16, Yongmin Tang17, Fan Lin1, Peihua Lu2, Chengjuan Luo3, Xiaojun Huang18,19.   

Abstract

Entities:  

Year:  2022        PMID： 36257981     DOI： 10.1038/s41409-022-01838-9

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  8 in total

1.  Fludarabine-based reduced intensity conditioning for stem cell transplantation of Fanconi anemia patients from fully matched related and unrelated donors.

Authors:  M Bitan; R Or; M Y Shapira; M Aker; I B Resnick; A Ackerstein; S Samuel; S Elad; S Slavin
Journal:  Biol Blood Marrow Transplant       Date:  2006-07       Impact factor: 5.742

2.  Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.

Authors:  L Torjemane; S Ladeb; T Ben Othman; A Abdelkefi; A Lakhal; A Ben Abdeladhim
Journal:  Pediatr Blood Cancer       Date:  2006-04       Impact factor: 3.167

Review 3.  How I manage patients with Fanconi anaemia.

Authors:  Carlo Dufour
Journal:  Br J Haematol       Date:  2017-05-05       Impact factor: 6.998

4.  Haplo-identical or mismatched unrelated donor hematopoietic cell transplantation for Fanconi anemia: Results from the Severe Aplastic Anemia Working Party of the EBMT.

Authors:  Josune Zubicaray; Daria Pagliara; Julian Sevilla; Dirk-Jan Eikema; Paul Bosman; Mouhab Ayas; Marco Zecca; Akif Yesilipek; Savas Kansoy; Cécile Renard; Jean H Dalle; Antonio Campos; Maura Faraci; Alphan Kupesiz; Frans J W Smiers; Andrea Velardi; Manuel Abecasis; Paola Corti; Franca Fagioli; Soledad González Muñiz; Gergely Kriván; Carlo Dufour; Antonio Risitano; Selim Corbacioglu; Régis Peffault de Latour
Journal:  Am J Hematol       Date:  2021-03-04       Impact factor: 10.047

5.  Radiation-free, alternative-donor HCT for Fanconi anemia patients: results from a prospective multi-institutional study.

Authors:  Parinda A Mehta; Stella M Davies; Thomas Leemhuis; Kasiani Myers; Nancy A Kernan; Susan E Prockop; Andromachi Scaradavou; Richard J O'Reilly; David A Williams; Leslie Lehmann; Eva Guinan; David Margolis; K Scott Baker; Adam Lane; Farid Boulad
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 6.  Transplantation for Fanconi anaemia: lessons learned from Brazil.

Authors:  Carmem Bonfim; Samantha Nichele; Gisele Loth; Vaneuza Araújo Moreira Funke; Samir Kanaan Nabhan; Daniela Vandresen Pillonetto; Alberto Cardoso Martins Lima; Ricardo Pasquini
Journal:  Lancet Haematol       Date:  2022-03       Impact factor: 18.959

7.  The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.

Authors:  Franco Locatelli; Marco Zecca; Andrea Pession; Giuseppe Morreale; Daniela Longoni; Paolo Di Bartolomeo; Fulvio Porta; Franca Fagioli; Bruno Nobili; Maria Ester Bernardo; Chiara Messina
Journal:  Haematologica       Date:  2007-10       Impact factor: 9.941

Review 8.  Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.

Authors:  Sonali Chaudhury; Arleen D Auerbach; Nancy A Kernan; Trudy N Small; Susan E Prockop; Andromachi Scaradavou; Glenn Heller; Suzanne Wolden; Richard J O'Reilly; Farid Boulad
Journal:  Br J Haematol       Date:  2008-03       Impact factor: 6.998
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.